China
Africa
Explore chapters and articles related to this topic
Papulosquamous Diseases
Published in Ayşe Serap Karadağ, Lawrence Charles Parish, Jordan V. Wang, Roxburgh's Common Skin Diseases, 2022
Melek Aslan Kayıran, Jordan V. Wang, Ayşe Serap Karadağ
Definition: This is a chronic, systemic inflammatory disease that affects the skin and is the most common papulosquamous disease. Numerous systemic effects, such as hyperlipidemia, cardiovascular disease, diabetes mellitus, depression, inflammatory bowel disease, nonalcoholic fatty liver disease, and metabolic syndrome may accompany it.
Bullae
Published in Giuseppe Micali, Pompeo Donofrio, Maria Rita Nasca, Stefano Veraldi, Vulval Dermatologic Diagnosis, 2015
Maria Rita Nasca, Giuseppe Micali
Differential diagnosis: Occasionally, the appearance may suggest a papulosquamous disorder. Seborrheic dermatitis, lupus erythematosus (acute, discoid, and subacute cutaneous), atopic dermatitis, and foliaceus or paraneoplastic pemphigus should be ruled out. Impetigo, glucagonoma syndrome, and subcorneal pustular dermatosis are other possible differential diagnoses.
Papulosquamous Skin Disorders in HIV Infection
Published in Clay J. Cockerell, Antoanella Calame, Cutaneous Manifestations of HIV Disease, 2012
Peter Morrell, Antoanella Calame, Clay J. Cockerell
Papulosquamous cutaneous diseases are a loosely defined category of dermatoses bound together by the fact that they all present clinically with scaly plaques and papules. In many cases, their exact etiologies are unknown. The major disease entities falling into this category include psoriasis, ‘parapsoriasis, pityriasis lichenoides et varioliformis acuta (PLEVA), pityriasis lichenoides chronica (PLC), lymphomatoid papulosis, pityriasis rosea (PR), pityriasis rubra pilaris (PRP), pityriasis alba (PA), lichen planus (LP), lichen striatus (LS), lichen nitidus (LN), and seborrheic dermatitis (SD). Some clinicians also include xerosis, acquired icthyosis, and asteatotic dermatitis, especially in human immunodeficiency virus (HIV)-positive patients.
Publication outcomes of abstracts presented at American Academy of Dermatology annual meeting
Published in Journal of Dermatological Treatment, 2022
Our analysis demonstrates considerable consistency in publication outcomes for abstracts presented at AAD Meetings for 2015 and 2016. Abstracts regarding papulosquamous disorders have publication outcomes higher than the average. Abstracts are published, on average, soon after one year of the date of presentation. Category-specific publication outcomes are varied. Most of the abstracts which were published appeared in JAAD, suggesting that abstracts presented may be more likely to be published in the host journal. Publication in non-peer-reviewed journals was observed for 8.5 and 7% of abstracts in 2015 and 2016, respectively. We found that 36.7 and 26.9% of abstracts published in non-peer-reviewed journals in 2015 and 2016 respectively were case reports, the most of any study design.
Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea
Published in Journal of Dermatological Treatment, 2018
Sidharth Sonthalia, Akshy Kumar, Vijay Zawar, Adity Priya, Pravesh Yadav, Sakshi Srivastava, Atula Gupta
Details of 70 patients were recorded, who were randomized into treatment (n = 35) and placebo (n = 35) groups. There were four drop outs; two each in each arm. In the oral prednisolone treatment arm, one patient could not be traced despite our best attempt, and the second patient informed telephonically that he became completely symptom-free within 5 days and expressed inability to come for follow-up. In the placebo arm, both patients could not come for follow-up; one had to shift to another city due to an emergency and the other became engaged with his father’s unexpected hospitalization. Out of 70 patients, 57 had the typical papulosquamous lesions, and 13 had papulovesicular lesions. Herald patch was recorded in 16 (23%) patients. The characteristics of patients in the two groups are depicted in Table 1. The two groups were comparable with respect to age and sex, duration of lesions, PRSS and VAS at baseline.
The efficacy of oral acyclovir during early course of pityriasis rosea: a systematic review and meta-analysis
Published in Journal of Dermatological Treatment, 2019
Hua-Ching Chang, Chih-Wei Sung, Ming-Hsiu Lin
PR is a common acute papulosquamous skin disorder. Clinically, only symptomatic relief treatment is administered to patients because of the disease’s self-limiting course. However, an unpredictable and prolonged course of PR may greatly affect a patient’s psychosocial status and quality of life (20). Antiviral agents, especially acyclovir, have been used for treating PR in several clinical trials because of accumulating evidence concerning the involvement of HHV-6 and HHV-7 in the etiology of various forms of PR (2).